Companies: 10,795·Total market cap: $144.5T
Cytek Biosciences, Inc.

Cytek Biosciences, Inc.

CTKBNASDAQHealthcare● Active
$4.04
$-0.05(-1.10%)
Market Cap$522368850
P/E Ratio
52W High$6.18
52W Low$2.9

Cytek Biosciences, Inc. (CTKB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CTKB · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Cytek Biosciences, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

CTKB insider buying and selling by quarter

CTKB insider selling · CTKB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
2.9M1.4M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · CTKB ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

CTKB executive sell shares · CTKB board member insider trading · CTKB insider trading SEC filing

Showing 60 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Holder Michael

Director

Option

Date

May 18

Shares

1,454

Price

Value

View Form 4 on SEC.gov

Chin Richard

Director

Option

Date

May 18

Shares

6,107

Price

Value

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Option

Date

May 18

Shares

9,480

Price

Value

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Other

Date

May 18

Shares

2,364

Price

$3.55

Value

$8K

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Option

Date

May 18

Shares

4,108

Price

Value

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Other

Date

May 18

Shares

1,025

Price

$3.55

Value

$4K

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Option

Date

May 18

Shares

3,683

Price

Value

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Other

Date

May 18

Shares

919

Price

$3.55

Value

$3K

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Option

Date

May 18

Shares

4,908

Price

Value

View Form 4 on SEC.gov

Yan Ming

CHIEF TECHNOLOGY OFFICER · Director

Other

Date

May 18

Shares

1,224

Price

$3.55

Value

$4K

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Option

Date

May 18

Shares

5,551

Price

Value

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Other

Date

May 18

Shares

1,424

Price

$3.55

Value

$5K

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Option

Date

May 18

Shares

2,416

Price

Value

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Other

Date

May 18

Shares

620

Price

$3.55

Value

$2K

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Option

Date

May 18

Shares

1,473

Price

Value

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Other

Date

May 18

Shares

378

Price

$3.55

Value

$1K

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Option

Date

May 18

Shares

1,024

Price

Value

View Form 4 on SEC.gov

Busque Philippe

SVP, GLOBAL SALES AND SERVICES

Other

Date

May 18

Shares

263

Price

$3.55

Value

$934

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Option

Date

May 18

Shares

38,141

Price

Value

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Other

Date

May 18

Shares

15,009

Price

$3.55

Value

$53K

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Option

Date

May 18

Shares

19,334

Price

Value

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Other

Date

May 18

Shares

5,032

Price

$3.55

Value

$18K

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Option

Date

May 18

Shares

14,733

Price

Value

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Other

Date

May 18

Shares

3,588

Price

$3.55

Value

$13K

View Form 4 on SEC.gov

Jiang Wenbin

PRESIDENT AND CEO · Director

Option

Date

May 18

Shares

7,854

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CTKB insider trading

CTKB insider trades

Cytek Biosciences, Inc. (CTKB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Busque Philippe (SVP, GLOBAL SALES AND SERVICES), Jiang Wenbin (PRESIDENT AND CEO · Director), Barnett Valerie (CHIEF LEGAL OFFICER). Over the past 12 months, 5 insiders have filed transactions with the SEC. CTKB insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Cytek Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

CTKB insider trading · 5 questions

The insiders of Cytek Biosciences, Inc. (CTKB) include executives and directors such as Busque Philippe (SVP, GLOBAL SALES AND SERVICES), Jiang Wenbin (PRESIDENT AND CEO · Director), Barnett Valerie (CHIEF LEGAL OFFICER), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CTKB board member insider tradingwho are CTKB insidersCTKB insider rosterCytek Biosciences, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026